News
Respondents broadly supported clearer guidance on how evidence on health inequalities should be presented and how impacts are ...
For well over a decade, scientists, health leaders, and global organisations have sounded the alarm on antimicrobial ...
Connecting 80+ EHS experts in pharma and biopharma on the West coast, this year's meeting will address the challenges of ...
Despite a certain amount of upheaval at the FDA, the agency has continued to keep up with its scheduled approvals and ...
Eli Lilly has won a green light from the FDA for new dosing for its Alzheimer's disease therapy Kisunla, which carries a ...
The deal for CARGO, which remains relatively well funded despite its troubles, comes with a contingent value right (CVR) that ...
The acquisition – which will see MSD pay $107 for each American Depository Share (ADS) in UK-headquartered Verona – is the ...
The high dose of Wegovy is one part of Novo Nordisk's plan to defend its obesity business, along with a major ...
After months of preparation and a drip-feed of some of its key features, the UK government has raised the curtain on its new 10-year plan for the NHS ...
This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie.
Whether stemming from early childhood adversity, combat exposure, or interpersonal abuse, trauma leaves long-term imprints on ...
Improving efficiencies and uncomplicating processes are critical to the future success of NHS Trusts across the country. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results